A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma

Journal of Molecular Medicine

Volumn 91, Issue 8, 2013, Pages 939-950

  Huidobro, Covadonga ^a   Toraño, Estela G ^a   Fernández, Agustín F ^a   Urdinguio, Rocío G ^a   Rodríguez, Ramón M ^a   Ferrero, Cecilia ^a   Martínez Camblor, Pablo ^b   Boix, Loreto ^c,f   Bruix, Jordi ^c,f   García Rodríguez, Juan Luís ^d   Varela Rey, Marta ^d   Mato, José María ^d   Martínez Chantar, María Luz ^d   Fraga, Mario F ^a,e  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b OIB   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CIC BIOGUNE   (Spain)

^e CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

5 Methylcytosine; Cancer; Epigenetics; S adenosylmethionine

Indexed keywords

GLYCINE METHYLTRANSFERASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DNA METHYLATION; EPIGENETIC REPRESSION; GENE REPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; PROMOTER REGION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA METHYLATION; EPIGENETIC REPRESSION; GLYCINE N-METHYLTRANSFERASE; HISTONES; HUMANS; LIVER NEOPLASMS; RNA, MESSENGER; S-ADENOSYLMETHIONINE;

EID: 84881230342     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-013-1010-8     Document Type: Article

References (50)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245-1255
3. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020-1022
4. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS (2005) Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42:218-224 (Pubitemid 40143468)
5. Fracanzani AL, Conte D, Fraquelli M, Taioli E, Mattioli M, Losco A, Fargion S (2001) Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology 33:647-651 (Pubitemid 32185227)
6. El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4:369-380 (Pubitemid 43343895)
7. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M et al (2002) Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123:134-140 (Pubitemid 34747534)
8. Thorgeirsson SS, Grisham JW (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339-346 (Pubitemid 35154440)
9. Kanai Y, Ushijima S, Hui AM, Ochiai A, Tsuda H, Sakamoto M, Hirohashi S (1997) The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 71:355-359 (Pubitemid 27224296)
10. Ito T, Nishida N, Fukuda Y, Nishimura T, Komeda T, Nakao K (2004) Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas. J Gastroenterol 39:355-361 (Pubitemid 38678784)
11. Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM, Johnson PJ (1999) Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 59:71-73 (Pubitemid 29062959)
12. Kerr SJ (1972) Competing methyltransferase systems. J Biol Chem 247:4248-4252
13. Uthus EO, Ross SA, Davis CD (2006) Differential effects of dietary selenium (se) and folate on methyl metabolism in liver and colon of rats. Biol Trace Elem Res 109:201-214 (Pubitemid 43780419)
14. Augoustides-Savvopoulou P, Luka Z, Karyda S, Stabler SP, Allen RH, Patsiaoura K, Wagner C, Mudd SH (2003) Glycine N-methyltransferase deficiency: a new patient with a novel mutation. J Inherit Metab Dis 26:745-759 (Pubitemid 38139376)
15. Mudd SH, Cerone R, Schiaffino MC, Fantasia AR, Minniti G, Caruso U, Lorini R, Watkins D, Matiaszuk N, Rosenblatt DS et al (2001) Glycine N-methyltransferase deficiency: a novel inborn error causing persistent isolated hypermethioninaemia. J Inherit Metab Dis 24:448-464 (Pubitemid 32894514)
16. Chen YM, Shiu JY, Tzeng SJ, Shih LS, Chen YJ, Lui WY, Chen PH (1998) Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int J Cancer 75:787-793 (Pubitemid 28145829)
17. Liu HH, Chen KH, Shih YP, Lui WY, Wong FH, Chen YM (2003) Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies. J Biomed Sci 10:87-97
18. Martinez-Chantar ML, Vazquez-Chantada M, Ariz U, Martinez N, Varela M, Luka Z, Capdevila A, Rodriguez J, Aransay AM, Matthiesen R et al (2008) Loss of the glycine N-methyl transferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 47:1191-1199 (Pubitemid 351547905)
19. Farber E, Ichinose H (1958) The prevention of ethionine-induced carcinoma of the liver in rats by methionine. Cancer Res 18:1209-1213
20. Pascale RM, Marras V, Simile MM, Daino L, Pinna G, Bennati S, Carta M, Seddaiu MA, Massarelli G, Feo F (1992) Chemoprevention of rat liver carcinogenesis by S-adenosyl-l-methionine: a long-term study. Cancer Res 52:4979-4986
21. Shivapurkar N, Hoover KL, Poirier LA (1986) Effect of methionine and choline on liver tumor promotion by phenobarbital and DDT in diethylnitrosamine-initiated rats. Carcinogenesis 7:547-550 (Pubitemid 17130488)
22. Balaghi M, Horne DW, Wagner C (1993) Hepatic one-carbon metabolism in early folate deficiency in rats. Biochem J 291(Pt 1):145-149 (Pubitemid 23107762)
23. Ogawa H, Gomi T, Takusagawa F, Fujioka M (1998) Structure, function and physiological role of glycine N-methyltransferase. Int J Biochem Cell Biol 30:13-26 (Pubitemid 28189492)
24. Wagner C, Briggs WT, Cook RJ (1985) Inhibition of glycine N-methyltransferase activity by folate derivatives: implications for regulation of methyl group metabolism. Biochem Biophys Res Commun 127:746-752 (Pubitemid 15037591)
25. Pascale RM, Simile MM, De Miglio MR, Nufris A, Daino L, Seddaiu MA, Rao PM, Rajalakshmi S, Sarma DS, Feo F (1995) Chemoprevention by S-adenosyl-l-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. Carcinogenesis 16:427-430
26. Liao YJ, Liu SP, Lee CM, Yen CH, Chuang PC, Chen CY, Tsai TF, Huang SF, Lee YH, Chen YM (2009) Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: implications of the gender disparity in liver cancer susceptibility. Int J Cancer 124:816-826
27. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32:e38
28. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408 (Pubitemid 34164012)
29. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63 (Pubitemid 14203433)
30. Shechter D, Dormann HL, Allis CD, Hake SB (2007) Extraction, purification and analysis of histones. Nat Protoc 2:1445-1457 (Pubitemid 46952324)
31. Ruthenburg AJ, Allis CD, Wysocka J (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25:15-30 (Pubitemid 46049068)
32. Zhang C, Li H, Zhou G, Zhang Q, Zhang T, Li J, Zhang J, Hou J, Liew CT, Yin D (2007) Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. J Pathol 212:134-142 (Pubitemid 46852091)
33. Fernandez AF, Assenov Y, Martin-Subero JI, Balint B, Siebert R, Taniguchi H, Yamamoto H, Hidalgo M, Tan AC, Galm O et al (2012) A DNA methylation fingerprint of 1628 human samples. Genome Res 22:407-419
34. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W et al (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39:237-242 (Pubitemid 46184356)
35. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE et al (2007) Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39:232-236 (Pubitemid 46184355)
36. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I et al (2007) Epigenetic stem cell signature in cancer. Nat Genet 39:157-158 (Pubitemid 46184343)
37. Mudd SH, Brosnan JT, Brosnan ME, Jacobs RL, Stabler SP, Allen RH, Vance DE, Wagner C (2007) Methyl balance and transmethylation fluxes in humans. Am J Clin Nutr 85:19-25 (Pubitemid 46067610)
38. Rowling MJ, McMullen MH, Schalinske KL (2002) Vitamin A and its derivatives induce hepatic glycine N-methyltransferase and hypomethylation of DNA in rats. J Nutr 132:365-369 (Pubitemid 34208734)
39. Appanah R, Dickerson DR, Goyal P, Groudine M, Lorincz MC (2007) An unmethylated 3′ promoter-proximal region is required for efficient transcription initiation. PLoS Genet 3:e27
40. Deaton AM, Webb S, Kerr AR, Illingworth RS, Guy J, Andrews R, Bird A (2011) Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Res 21:1074-1086
41. -/- mice develop chronic hepatitis and glycogen storage disease in the liver. Hepatology 46:1413-1425 (Pubitemid 350155523)
42. Luka Z, Capdevila A, Mato JM, Wagner C (2006) A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme. Transgenic Res 15:393-397 (Pubitemid 43901497)
43. Wang YC, Tang FY, Chen SY, Chen YM, Chiang EP (2011) Glycine-N methyltransferase expression in HepG2 cells is involved in methyl group homeostasis by regulating transmethylation kinetics and DNA methylation. J Nutr 141:777-782
44. Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, Nicola NA, Hilton DJ, Alexander WS (2000) Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405:1069-1073 (Pubitemid 30447793)
45. Schultheis B, Carapeti-Marootian M, Hochhaus A, Weisser A, Goldman JM, Melo JV (2002) Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanism. Blood 99:1766-1775 (Pubitemid 34533052)
46. Sutherland KD, Lindeman GJ, Choong DY, Wittlin S, Brentzell L, Phillips W, Campbell IG, Visvader JE (2004) Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene 23:7726-7733 (Pubitemid 39424931)
47. Buckbinder L, Velasco-Miguel S, Chen Y, Xu N, Talbott R, Gelbert L, Gao J, Seizinger BR, Gutkind JS, Kley N (1997) The p53 tumor suppressor targets a novel regulator of G protein signaling. Proc Natl Acad Sci U S A 94:7868-7872 (Pubitemid 27343741)
48. Liang G, Bansal G, Xie Z, Druey KM (2009) RGS16 inhibits breast cancer cell growth by mitigating phosphatidylinositol 3-kinase signaling. J Biol Chem 284:21719-21727
49. Cheng CJ, Lin YC, Tsai MT, Chen CS, Hsieh MC, Chen CL, Yang RB (2009) SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer. Cancer Res 69:3634-3641
50. Sherman M (2010) The resurrection of alphafetoprotein. J Hepatol 52:939-940